184 related articles for article (PubMed ID: 9520171)
1. Treatment of HIV-related fluconazole-resistant oral candidosis with D0870, a new triazole antifungal.
Cartledge JD; Denning DW; Dupont B; Clumeck N; De Wit S; Midgley J; Hawkins DA; Gazzard BG
AIDS; 1998 Mar; 12(4):411-6. PubMed ID: 9520171
[TBL] [Abstract][Full Text] [Related]
2. A dose comparison study of a new triazole antifungal (D0870) in HIV-positive patients with oral candidiasis.
De Wit S; Dupont B; Cartledge JD; Hawkins DA; Gazzard BG; Clumeck N; Denning DW
AIDS; 1997 May; 11(6):759-63. PubMed ID: 9143608
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of a new antifungal triazole, D0870, against Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus.
Barchiesi F; Colombo AL; McGough DA; Fothergill AW; Rinaldi MG
Antimicrob Agents Chemother; 1994 Nov; 38(11):2553-6. PubMed ID: 7872746
[TBL] [Abstract][Full Text] [Related]
4. Colorimetric MTT assessment of antifungal activity of D0870 against fluconazole-resistant Candida albicans.
Yang HC; Mikami Y; Yazawa K; Taguchi H; Nishimura K; Miyaji M; Branchini ML; Aoki FH; Yamamoto K
Mycoses; 1998 Dec; 41(11-12):477-80. PubMed ID: 9919890
[TBL] [Abstract][Full Text] [Related]
5. Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis.
Barchiesi F; Arzeni D; Del Prete MS; Sinicco A; Falconi Di Francesco L; Pasticci MB; Lamura L; Nuzzo MM; Burzacchini F; Coppola S; Chiodo F; Scalise G
J Antimicrob Chemother; 1998 May; 41(5):541-8. PubMed ID: 9630407
[TBL] [Abstract][Full Text] [Related]
6. Assessment of therapeutic response of oropharyngeal and esophageal candidiasis in AIDS with use of a new clinical scoring system: studies with D0870.
Hood SV; Hollis S; Percy M; Atkinson G; Williams K; Denning DW
Clin Infect Dis; 1999 Mar; 28(3):587-96. PubMed ID: 10194083
[TBL] [Abstract][Full Text] [Related]
7. [Antifungal activities of D0870 against fluconazole-resistant Candida albicans].
Kojima M; Yamada H; Nakamura S; Kikuchi M; Nakanishii T; Takahashi Y; Mochizuki H; Mikami Y
Nihon Ishinkin Gakkai Zasshi; 1999; 40(4):209-15. PubMed ID: 10536307
[TBL] [Abstract][Full Text] [Related]
8. Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis.
Cartledge JD; Midgley J; Gazzard BG
AIDS; 1997 Dec; 11(15):1839-44. PubMed ID: 9412702
[TBL] [Abstract][Full Text] [Related]
9. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
[TBL] [Abstract][Full Text] [Related]
10. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection.
Ruhnke M; Eigler A; Tennagen I; Geiseler B; Engelmann E; Trautmann M
J Clin Microbiol; 1994 Sep; 32(9):2092-8. PubMed ID: 7814530
[TBL] [Abstract][Full Text] [Related]
11. Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
Saag MS; Fessel WJ; Kaufman CA; Merrill KW; Ward DJ; Moskovitz BL; Thomas C; Oleka N; Guarnieri JA; Lee J; Brenner-Gati L; Klausner M
AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1413-7. PubMed ID: 10555103
[TBL] [Abstract][Full Text] [Related]
12. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis.
Johnson EM; Warnock DW; Luker J; Porter SR; Scully C
J Antimicrob Chemother; 1995 Jan; 35(1):103-14. PubMed ID: 7768758
[TBL] [Abstract][Full Text] [Related]
13. Response to fluconazole by 23 patients with human immunodeficiency virus infection and oral candidiasis: pharmacological and mycological factors.
Lacassin F; Damond F; Chochillon C; Longuet P; Lebras J; Vilde JL; Leport C
Antimicrob Agents Chemother; 1996 Aug; 40(8):1961-3. PubMed ID: 8843316
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of D0870 treatment of experimental Candida vaginitis.
Fidel PL; Cutright JL; Sobel JD
Antimicrob Agents Chemother; 1997 Jul; 41(7):1455-9. PubMed ID: 9210665
[TBL] [Abstract][Full Text] [Related]
15. Unresponsive HIV-related oro-oesophageal candidosis--an evaluation of two new in-vitro azole susceptibility tests.
Cartledge JD; Midgley J; Petrou M; Shanson D; Gazzard BG
J Antimicrob Chemother; 1997 Oct; 40(4):517-23. PubMed ID: 9372421
[TBL] [Abstract][Full Text] [Related]
16. Correlation between antifungal susceptibility testing of Candida isolates from patients with HIV infection and clinical results after treatment with fluconazole.
Ruhnke M; Eigler A; Engelmann E; Geiseler B; Trautmann M
Infection; 1994; 22(2):132-6. PubMed ID: 8070927
[TBL] [Abstract][Full Text] [Related]
17. Relative growth measurement of Candida species in a single concentration of fluconazole predicts the clinical response to fluconazole in HIV infected patients with oral candidosis.
Cartledge JD; Midgley J; Gazzard BG
J Antimicrob Chemother; 1996 Feb; 37(2):275-83. PubMed ID: 8707737
[TBL] [Abstract][Full Text] [Related]
18. [Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole].
Metzger S; Hofmann H
Mycoses; 1997; 40 Suppl 1():56-63. PubMed ID: 9417515
[TBL] [Abstract][Full Text] [Related]
19. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
[TBL] [Abstract][Full Text] [Related]
20. Transmission of fluconazole-resistant Candida albicans between patients with AIDS and oropharyngeal candidiasis documented by pulsed-field gel electrophoresis.
Barchiesi F; Hollis RJ; Del Poeta M; McGough DA; Scalise G; Rinaldi MG; Pfaller MA
Clin Infect Dis; 1995 Sep; 21(3):561-4. PubMed ID: 8527544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
